Russell Investments Group
HRMY icon

Russell Investments Group’s Harmony Biosciences HRMY Stock Holding History

Russell Investments Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
33,341
+6,257
+23% +$197K ﹤0.01% 2369
2026
Q1 		$759K Sell
27,084
-1,994
-7% -$65.4K ﹤0.01% 2343
2025
Q4 		$1.09M Buy
29,078
+6,288
+28% +$207K ﹤0.01% 2184
2025
Q3 		$628K Sell
22,790
-6,766
-23% -$233K ﹤0.01% 2383
2025
Q2 		$934K Sell
29,556
-2,342
-7% -$75.3K ﹤0.01% 2093
2025
Q1 		$1.06M Sell
31,898
-14,651
-31% -$525K ﹤0.01% 2011
2024
Q4 		$1.6M Sell
46,549
-5,474
-11% -$188K ﹤0.01% 1777
2024
Q3 		$2.08M Buy
52,023
+44,446
+587% +$1.56M ﹤0.01% 1675
2024
Q2 		$229K Sell
7,577
-26,404
-78% -$794K ﹤0.01% 2446
2024
Q1 		$1.14M Buy
33,981
+5,082
+18% +$163K ﹤0.01% 1927
2023
Q4 		$933K Sell
28,899
-18,209
-39% -$508K ﹤0.01% 1996
2023
Q3 		$1.54M Buy
47,108
+22,114
+88% +$768K ﹤0.01% 1699
2023
Q2 		$880K Sell
24,994
-11,911
-32% -$411K ﹤0.01% 1996
2023
Q1 		$1.2M Sell
36,905
-82,758
-69% -$3.77M ﹤0.01% 1870
2022
Q4 		$6.59M Sell
119,663
-62,671
-34% -$3.45M 0.01% 959
2022
Q3 		$8.07M Buy
182,334
+112,474
+161% +$5.49M 0.02% 828
2022
Q2 		$3.41M Buy
69,860
+57,304
+456% +$2.58M 0.01% 1295
2022
Q1 		$613K Buy
12,556
+4,363
+53% +$178K ﹤0.01% 2158
2021
Q4 		$348K Buy
8,193
+2,321
+40% +$92.5K ﹤0.01% 2552
2021
Q3 		$224K Buy
+5,872
New +$189K ﹤0.01% 2745
2020
Q4 		– Sell
-12,275
Closed -$414K – 3112
2020
Q3 		$414K Buy
+12,275
New +$448K ﹤0.01% 2479

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Russell Investments Group's HRMY Position: Q2 2026 in Review

Russell Investments Group increased its Harmony Biosciences (HRMY) stake by 23% in Q2 2026, buying an estimated $197K and bringing the position to 33,341 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2369.

Russell Investments Group first reported a position in HRMY in Q3 2020 and has held it in 21 quarters since. The position peaked at $8.07M in Q3 2022. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Russell Investments Group held 33,341 shares of Harmony Biosciences worth $1.21M as of Q2 2026.
  • Russell Investments Group bought 6,257 Harmony Biosciences shares in Q2 2026, an estimated $197K.
  • Harmony Biosciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2369 holding.
  • Russell Investments Group first reported a position in Harmony Biosciences in Q3 2020 and has held it in 21 quarters since.
  • Russell Investments Group's Harmony Biosciences position peaked at $8.07M in Q3 2022.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.